GlassScriptPhysician profile
Maureen Williams
NPI 1417567454
$1,215.46
in general payments reported to CMS, 2019-2025
14 companies · $606 in 2025
The $606 reported for 2025 was more than what 76% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $55.46 · 2024: $554 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $211.21 | 2024-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $161.18 | 2024 | Xarelto |
| Medtronic, INC. | $140.78 | 2025 | In.Pact Admiral |
| Abiomed | $140.03 | 2024 | Impella |
| Alnylam Pharmaceuticals INC. | $118.74 | 2025 | Amvuttra |
| Scpharmaceuticals INC. | $104.33 | 2024-2025 | |
| Biotronik INC. | $103.90 | 2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Kestra Medical Technology Services, INC. | $77.39 | 2023-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $46.93 | 2025 | Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.22 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $26.74 | 2025 | Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $24.16 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.59 | 2024 | |
| Merck Sharp & Dohme LLC | $16.26 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.